Version: 1.0.0 | Published: 8 Oct 2024 | Updated: 229 days ago
Documentation
Description:
Beta-blocker Stratification using quantitative MRI techniques to assess portal pressure and Response to Treatment in patients with portal hypertension (B-SMaRT study).
To provide proof of concept that quantitative haemodynamic MRI markers can stratify the efficacy of carvedilol to lower clinically significant portal hypertension in patients with cirrhosis.
Descriptive sequential pilot study of patients with cirrhosis, portal pressure measurement, research MRI (at 3T) and endoscopy with outcomes with repeat measures in those who are given Carvedilol
Coverage
Spatial:
United Kingdom,England,East Midlands
Typical Age Range:
18-80
Follow Up:
1 - 10 Years
Pathway:
Secondary Care
Provenance
Origin
Purposes:
Study
Sources:
Paper-based
Collection Situations:
Secondary care - Outpatients
Temporal
Accrual Periodicity:
Irregular
Start Date:
01 August 2016
Time Lag:
Variable
Accessibility
Access
Access Rights:
In Progress
Delivery Lead Time:
Not applicable
Jurisdictions:
GB-ENG
Data Controller:
Professor Guruprasad Aithal
Data Processor:
N/A
Usage
Data Use Limitations:
General research use
Resource Creators:
NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust
Format and Standards
Vocabulary Encoding Schemes:
LOCAL
Languages:
en
Formats:
Database
Observations
Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Persons
46
Count
01 August 2016